Resultaterne af undersøgelsen blev analyseret hos henholdsvis 243 patienter, hvis tumorer indeholdt ikke- muteret KRAS, og 184 patienter, hos hvem KRAS- genet indeholdt en mutation.
The results of the study were analysed separately in 243 patients whose tumours contained KRAS that had not mutated and in 184 patients in whom the KRAS gene contained a mutation.